CAC Score Improves Coronary and CV Risk Assessment Above Statin Indication by ESC and AHA/ACC Primary Prevention Guidelines | Zendy

Amir A. Mahabadi | Zendy; Stefan Möhlenkamp | Zendy; Nils Lehmann | Zendy; Hagen Kälsch | Zendy; Iryna Dykun | Zendy; Noreen Pundt | Zendy; Susanne Moebus | Zendy; KarlHeinz Jöckel | Zendy; Raimund Erbel | Zendy; Heinz Nixdorf Recall Study Investigators | Zendy

Open Access

CAC Score Improves Coronary and CV Risk Assessment Above Statin Indication by ESC and AHA/ACC Primary Prevention Guidelines

Author(s) -

Amir A. Mahabadi,

Stefan Möhlenkamp,

Nils Lehmann,

Hagen Kälsch,

Iryna Dykun,

Noreen Pundt,

Susanne Moebus,

KarlHeinz Jöckel,

Raimund Erbel,

Heinz Nixdorf Recall Study Investigators

Publication year - 2017

Publication title -

jacc. cardiovascular imaging

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.79

H-Index - 120

eISSN - 1936-878X

pISSN - 1876-7591

DOI - 10.1016/j.jcmg.2016.03.022

Subject(s) - medicine , statin , confidence interval , cardiology , cohort , primary prevention , coronary artery disease , population , myocardial infarction , atherosclerotic cardiovascular disease , framingham risk score , disease , environmental health

The aim of this study was to assess the difference in indication for statin therapy by European Society of Cardiology (ESC) versus American Heart Association/American College of Cardiology (AHA/ACC) guidelines and to quantify the potential additional role of coronary artery calcification (CAC) score over updated guidelines in a primary prevention cohort.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research